Arvinas (ARVN) Common Equity (2016 - 2026)
Arvinas (ARVN) reported Common Equity of $513.8 million for Q3 2026, down 9.0% from $564.4 million a year earlier and down 8.6% from the prior quarter.
Powered by 
Analysis
Arvinas (ARVN) Common Equity (2016 - 2026) Analysis & Trends
At the end of FY2025, Arvinas posted Common Equity of $433.9 million, down 22.8% from FY2024.
- Common Equity has a five-year compound annual growth rate of -7.5% (FY2020 to FY2025).
- By year, Common Equity came in at $561.7 million in FY2024 (-14.9%), $660 million in FY2023 (+16.8%), $564.9 million in FY2022 (-27.7%) and $781.7 million in FY2021 (+21.7%).
- Five-year quarterly Common Equity spans a low of $386.8 million in Q1 2026 and a high of $781.7 million in Q4 2021.
- Year over year, Common Equity has now declined in each of the last five quarters, with an average decline of 11.2% over the last eight quarters.
- The high point for year-over-year Common Equity in five years was Q2 2024 (growth of 29.5%); the low point was Q1 2026 (a decline of 41.4%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $562.2 million (Q2 2026), $386.8 million (Q1 2026) and $433.9 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Arvinas | 453.26 Mn | -1.97 Bn | 400,000.00 | 513.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 513.80 Mn |
| Jun 30, 2026 | 562.20 Mn |
| Mar 31, 2026 | 386.80 Mn |
| Dec 31, 2025 | 433.90 Mn |
| Sep 30, 2025 | 564.40 Mn |
| Jun 30, 2025 | 609.30 Mn |
| Mar 31, 2025 | 660.10 Mn |
| Dec 31, 2024 | 561.70 Mn |
| Sep 30, 2024 | 586.00 Mn |
| Jun 30, 2024 | 600.20 Mn |
| Mar 31, 2024 | 609.70 Mn |
| Dec 31, 2023 | 660.00 Mn |
| Sep 30, 2023 | 457.20 Mn |
| Jun 30, 2023 | 463.60 Mn |
| Mar 31, 2023 | 511.00 Mn |
| Dec 31, 2022 | 564.90 Mn |
| Sep 30, 2022 | 621.50 Mn |
| Jun 30, 2022 | 670.60 Mn |
| Mar 31, 2022 | 723.30 Mn |
| Dec 31, 2021 | 781.70 Mn |
API Access
Arvinas Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ARVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ARVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ARVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();